started · updated
Dermatologists emphasize safety in collagen stimulator selection
Medical experts are highlighting the importance of safety, product quality, and clinical evidence when selecting collagen stimulators for skin aging treatments. As natural collagen production declines with age, leading to wrinkles and loss of elasticity, regenerative aesthetics has emerged as a field focused on supporting the body's biological processes to repair tissue.
One prominent method involves using biostimulators, such as poly-L-lactic acid (PLLA), to trigger the body's own collagen formation. Experts note that because these treatments are administered via injection, they require assessment by competent medical professionals to manage potential risks and tailor treatments to individual patient needs.
In a related development, the Swedish biotechnology company Nordberg Medical is scheduled to launch its Julaine of Sweden injection-based product in Indonesia in 2026.
Entities
Deasy Lius · Indonesia · Julaine of Sweden · Nordberg Medical · Sweden